3-D Matrix,Ltd. (7777)

Market cap
¥54.7B
P/E ratio
59.2x
Three-D Matrix develops and sells medical devices and pharmaceuticals using exclusive MIT-licensed self-assembling peptide technology for surgery, tissue regeneration, and drug delivery.
Period EndShort-term debt (Million JPY)YoY (%)
Apr 30, 2025300+0.00%
Apr 30, 2024300-40.00%
Apr 30, 2023500+25.00%
Apr 30, 2022400-1.86%
Apr 30, 2021408+1.90%
Apr 30, 2020400-27.27%
Apr 30, 2019550+22.22%
Apr 30, 2018450+0.00%
Apr 30, 2017450+125.00%
Apr 30, 2016200+0.00%
Apr 30, 2015200
AI Chat